chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Runny nose; Sore throat; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose) and OROPHARYNGEAL PAIN (Sore throat) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced RHINORRHOEA (Runny nose) and OROPHARYNGEAL PAIN (Sore throat). At the time of the report, RHINORRHOEA (Runny nose) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling abnormal, Pruritus, Swelling
Clinical narrative: bit of feeling; Circle of redness spread over 2 in diameter; Swelling in the middle; Extreme itching; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (bit of feeling), ERYTHEMA (Circle of redness spread over 2 in diameter), SWELLING (Swelling in the middle) and PRURITUS (Extreme itching) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included Hypothyroidism.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced ERYTHEMA (Circle of redness spread over 2 in diameter), SWELLING (Swelling in the middle) and PRURITUS (Extreme itching). On an unknown date, the patient experienced FEELING ABNORMAL (bit of feeling). At the time of the report, FEELING ABNORMAL (bit of feeling), ERYTHEMA (Circle of redness spread over 2 in diameter), SWELLING (Swelling in the middle) and PRURITUS (Extreme itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizzy for about 15 seconds; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy for about 15 seconds) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced DIZZINESS (Dizzy for about 15 seconds). On 12-Feb-2021, DIZZINESS (Dizzy for about 15 seconds) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  Treatment information was not provided. .   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received on 23-jul-2021 and contains non-significant information
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Arthralgia, Chills, Decreased appetite
Clinical narrative: Loss of appetite; Loss of taste; Loss of smell; Fever; Chills; Nausea; Joint ache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), PYREXIA (Fever) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced DECREASED APPETITE (Loss of appetite), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), ARTHRALGIA (Joint ache) and FATIGUE (Fatigue). On 09-Mar-2021, DECREASED APPETITE (Loss of appetite), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), ARTHRALGIA (Joint ache) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pyrexia
Clinical narrative: Loss of appetite; Loss of taste; Loss of smell; Fever; Chills; Nausea; Joint ache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), PYREXIA (Fever) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced DECREASED APPETITE (Loss of appetite), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), ARTHRALGIA (Joint ache) and FATIGUE (Fatigue). On 09-Mar-2021, DECREASED APPETITE (Loss of appetite), AGEUSIA (Loss of taste), ANOSMIA (Loss of smell), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea), ARTHRALGIA (Joint ache) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Skin mass
Clinical narrative: 3 small lumps under her chin; This spontaneous case was reported by a physician and describes the occurrence of SKIN MASS (3 small lumps under her chin) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. EYT721824) for COVID-19 vaccination.     The patient's past medical history included Cancer (Needs to get a control mammogram before April.) in 2003. Concurrent medical conditions included Diabetes, Heart disorder and Overweight (little overweight.).    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN MASS (3 small lumps under her chin). At the time of the report, SKIN MASS (3 small lumps under her chin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information included "hydrating lotion for diabetics dry skin relief" on the affected area.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Nodule, Vaccination site pain
Clinical narrative: lump under arm pit; neck pain; severe pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck pain), NODULE (lump under arm pit) and VACCINATION SITE PAIN (severe pain at the injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE PAIN (severe pain at the injection site). On 22-Feb-2021, the patient experienced NECK PAIN (neck pain). On 26-Feb-2021, the patient experienced NODULE (lump under arm pit). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 22-Feb-2021, VACCINATION SITE PAIN (severe pain at the injection site) outcome was unknown. At the time of the report, NECK PAIN (neck pain) and NODULE (lump under arm pit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Paraesthesia, Paraesthesia oral
Clinical narrative: Tingling of lips; numbness of the face; Tingling of the face/ Tingling on scalp/ Tingling of fingers; Numbness of lips; Numbness on scalp; Numbness on fingers; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA ORAL (Tingling of lips), HYPOAESTHESIA (numbness of the face), PARAESTHESIA (Tingling of the face/ Tingling on scalp/ Tingling of fingers), HYPOAESTHESIA ORAL (Numbness of lips) and HYPOAESTHESIA (Numbness on scalp) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA ORAL (Tingling of lips), HYPOAESTHESIA (numbness of the face), PARAESTHESIA (Tingling of the face/ Tingling on scalp/ Tingling of fingers), HYPOAESTHESIA ORAL (Numbness of lips), HYPOAESTHESIA (Numbness on scalp) and HYPOAESTHESIA (Numbness on fingers). At the time of the report, PARAESTHESIA ORAL (Tingling of lips), HYPOAESTHESIA (numbness of the face), PARAESTHESIA (Tingling of the face/ Tingling on scalp/ Tingling of fingers), HYPOAESTHESIA ORAL (Numbness of lips), HYPOAESTHESIA (Numbness on scalp) and HYPOAESTHESIA (Numbness on fingers) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Chills, Gait disturbance, Myalgia, Pyrexia
Clinical narrative: deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk; chills; deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk; fever; deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk), BONE PAIN (deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk), PYREXIA (fever), CHILLS (chills) and MYALGIA (deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (august 2020 0r September 2020).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced GAIT DISTURBANCE (deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk), PYREXIA (fever) and MYALGIA (deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk). On 19-Mar-2021, the patient experienced CHILLS (chills). On an unknown date, the patient experienced BONE PAIN (deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk). The patient was treated with PARACETAMOL (TYLENOL) for Fever and Chills, at a dose of 1 dosage form. At the time of the report, GAIT DISTURBANCE (deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk), BONE PAIN (deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk), PYREXIA (fever), CHILLS (chills) and MYALGIA (deep muscle aches/achy down to the bone/terrible body aches down to bones where she could barely walk) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided   Most recent FOLLOW-UP information incorporated above includes: On 18-Mar-2021: Follow up received on 18-Mar-2021 and medical history was added.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pyrexia, Rash, Vaccination site erythema
Clinical narrative: Fever; rash all over the body; pain at injection site; arm was swollen; arm was red; feeling chills; left arm hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (left arm hot), RASH (rash all over the body), VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (arm was red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy (Multiple unspecified allergies).  On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 04-Feb-2021, the patient experienced VACCINATION SITE WARMTH (left arm hot). On 04-Mar-2021, the patient experienced RASH (rash all over the body), VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE SWELLING (arm was swollen), VACCINATION SITE ERYTHEMA (arm was red) and CHILLS (feeling chills).   On 05-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy, at an unspecified dose and frequency.   At the time of the report, VACCINATION SITE WARMTH (left arm hot), RASH (rash all over the body), VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE SWELLING (arm was swollen), VACCINATION SITE ERYTHEMA (arm was red), CHILLS (feeling chills) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: 100 (High) 100 degrees Fahrenheit.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Fever; rash all over the body; pain at injection site; arm was swollen; arm was red; feeling chills; left arm hot; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (left arm hot), RASH (rash all over the body), VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE SWELLING (arm was swollen) and VACCINATION SITE ERYTHEMA (arm was red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy (Multiple unspecified allergies).  On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 04-Feb-2021, the patient experienced VACCINATION SITE WARMTH (left arm hot). On 04-Mar-2021, the patient experienced RASH (rash all over the body), VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE SWELLING (arm was swollen), VACCINATION SITE ERYTHEMA (arm was red) and CHILLS (feeling chills).   On 05-Mar-2021, the patient experienced PYREXIA (Fever). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (ALLERGY [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy, at an unspecified dose and frequency.   At the time of the report, VACCINATION SITE WARMTH (left arm hot), RASH (rash all over the body), VACCINATION SITE PAIN (pain at injection site), VACCINATION SITE SWELLING (arm was swollen), VACCINATION SITE ERYTHEMA (arm was red), CHILLS (feeling chills) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Mar-2021, Body temperature: 100 (High) 100 degrees Fahrenheit.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash
Clinical narrative: Rash on her breast around nipple; Rash at the injection/Two rash near injection site; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of RASH (Rash on her breast around nipple) and VACCINATION SITE RASH (Rash at the injection/Two rash near injection site) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 05-Mar-2021, the patient experienced RASH (Rash on her breast around nipple) and VACCINATION SITE RASH (Rash at the injection/Two rash near injection site).   On 06-Mar-2021, RASH (Rash on her breast around nipple) had resolved. At the time of the report, VACCINATION SITE RASH (Rash at the injection/Two rash near injection site) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medication were not provided. The patient went to urgent care and they told her to put over counter cream on the area.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Eye movement disorder, Lip swelling, Nervousness, Palpitations, Product dose omission issue
Clinical narrative: More than 35 days from first dose; tongue swelling; LIP SWELLING; heart racing; eyes felt funny; nervous; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (tongue swelling), LIP SWELLING (LIP SWELLING), PALPITATIONS (heart racing), EYE MOVEMENT DISORDER (eyes felt funny) and NERVOUSNESS (nervous) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced NERVOUSNESS (nervous). On 09-Mar-2021, the patient experienced SWOLLEN TONGUE (tongue swelling), LIP SWELLING (LIP SWELLING), PALPITATIONS (heart racing) and EYE MOVEMENT DISORDER (eyes felt funny). On 22-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 35 days from first dose). At the time of the report, SWOLLEN TONGUE (tongue swelling), LIP SWELLING (LIP SWELLING), PALPITATIONS (heart racing), EYE MOVEMENT DISORDER (eyes felt funny), NERVOUSNESS (nervous) and PRODUCT DOSE OMISSION ISSUE (More than 35 days from first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 22-Jun-2021: Event was added.  No treatment information was reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: More than 35 days from first dose; tongue swelling; LIP SWELLING; heart racing; eyes felt funny; nervous; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (tongue swelling), LIP SWELLING (LIP SWELLING), PALPITATIONS (heart racing), EYE MOVEMENT DISORDER (eyes felt funny) and NERVOUSNESS (nervous) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced NERVOUSNESS (nervous). On 09-Mar-2021, the patient experienced SWOLLEN TONGUE (tongue swelling), LIP SWELLING (LIP SWELLING), PALPITATIONS (heart racing) and EYE MOVEMENT DISORDER (eyes felt funny). On 22-Jun-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 35 days from first dose). At the time of the report, SWOLLEN TONGUE (tongue swelling), LIP SWELLING (LIP SWELLING), PALPITATIONS (heart racing), EYE MOVEMENT DISORDER (eyes felt funny), NERVOUSNESS (nervous) and PRODUCT DOSE OMISSION ISSUE (More than 35 days from first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 22-Jun-2021: Event was added.  No treatment information was reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: nausea getting worse; nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) and NAUSEA (nausea getting worse) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011a21a) for COVID-19 vaccination.     no medical history was provided.  Concomitant products included DULOXETINE, AZILSARTAN KAMEDOXOMIL (EDARBI) and FUROSEMIDE (FUROfEMIDE) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced NAUSEA (nausea). On 09-Mar-2021, the patient experienced NAUSEA (nausea getting worse). At the time of the report, NAUSEA (nausea) and NAUSEA (nausea getting worse) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.